154 related articles for article (PubMed ID: 38555517)
1. Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches.
Li C; Xiao Y; Kong J; Lai C; Chen Z; Li Z; Xie W
Cell Adh Migr; 2024 Dec; 18(1):1-17. PubMed ID: 38555517
[TBL] [Abstract][Full Text] [Related]
2. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
Yang Y; Ye F; Xia T; Wang Q; Du J
BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
[TBL] [Abstract][Full Text] [Related]
3. MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours.
McGarry DJ; Armstrong G; Castino G; Mason S; Clark W; Shaw R; McGarry L; Blyth K; Olson MF
Cancer Lett; 2021 Oct; 519():226-236. PubMed ID: 34314753
[TBL] [Abstract][Full Text] [Related]
4. PlexinA1 promotes gastric cancer migration through preventing MICAL1 protein ubiquitin/proteasome-mediated degradation in a Rac1-dependent manner.
Ye F; Xia T; Zhao M; Zhao W; Min P; Wang Y; Wang Q; Zhang Y; Du J
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167124. PubMed ID: 38508474
[TBL] [Abstract][Full Text] [Related]
5. MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway.
Deng W; Wang Y; Zhao S; Zhang Y; Chen Y; Zhao X; Liu L; Sun S; Zhang L; Ye B; Du J
J Cell Mol Med; 2018 Jun; 22(6):3108-3118. PubMed ID: 29524295
[TBL] [Abstract][Full Text] [Related]
6.
Haikazian S; Olson MF
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627100
[TBL] [Abstract][Full Text] [Related]
7. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
[TBL] [Abstract][Full Text] [Related]
8. MICAL1 (molecule interacting with CasL 1) protects oligodendrocyte cells from oxidative injury through regulating apoptosis, autophagy in spinal cord injury.
Xu C; Mao L; Tian H; Lin S; Zhao X; Lin J; Li D; Li X; Mei X
Neurosci Lett; 2021 Apr; 750():135712. PubMed ID: 33647394
[TBL] [Abstract][Full Text] [Related]
9. MICAL1 controls cell invasive phenotype via regulating oxidative stress in breast cancer cells.
Deng W; Wang Y; Gu L; Duan B; Cui J; Zhang Y; Chen Y; Sun S; Dong J; Du J
BMC Cancer; 2016 Jul; 16():489. PubMed ID: 27430308
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics Analyses Reveal Function of Apolipoprotein E in Alternative Splicing and Tumor Immune Microenvironment in Kidney Renal Clear Cell Carcinoma via Pan-cancer Analysis.
Leng X; Liu J; Jin A; Zheng H; Wu J; Zhong L; Li Q; Li D
Cell Biochem Biophys; 2024 Mar; 82(1):1-13. PubMed ID: 38182861
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract][Full Text] [Related]
12. Actin filament oxidation by MICAL1 suppresses protections from cofilin-induced disassembly.
Wioland H; Frémont S; Guichard B; Echard A; Jégou A; Romet-Lemonne G
EMBO Rep; 2021 Feb; 22(2):e50965. PubMed ID: 33393173
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
[No Abstract] [Full Text] [Related]
14. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma.
Liu Y; Zhang Z; Xi P; Chen R; Cheng X; Liu J; Zhu Q; Nie Y; Sun T; Gong B; Wang S
BMC Cancer; 2023 Sep; 23(1):837. PubMed ID: 37679715
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
[TBL] [Abstract][Full Text] [Related]
17. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins.
Romaschin AD; Youssef Y; Chow TF; Siu KW; DeSouza LV; Honey RJ; Stewart R; Pace KT; Yousef GM
Biol Chem; 2009 Feb; 390(2):125-35. PubMed ID: 19090715
[TBL] [Abstract][Full Text] [Related]
18. MICAL1 activation by PAK1 mediates actin filament disassembly.
McGarry DJ; Castino G; Lilla S; Carnet A; Kelly L; Micovic K; Zanivan S; Olson MF
Cell Rep; 2022 Oct; 41(1):111442. PubMed ID: 36198272
[TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
